Neoplasia
17
6
6
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
1 terminated out of 17 trials
88.9%
+2.4% vs benchmark
12%
2 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (17)
Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative Treatment for Cervical Intra-epithelial Neoplasia
The Radiation Oncology Registry and Biosample Repository
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
The Suitability of Sniff Dog as a Tool in Screening Tumors
The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
The Drug Rediscovery Protocol (DRUP Trial)
Genetic Factors and Pheochromocytomas in Neoplasia Type 2
A Study of ASN007 in Patients With Advanced Solid Tumors
Cervical Cancer Early Endpoints and Determinants
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
Optical Imaging of Head and Neck Cancer
Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial
Radiofrequency Ablation for the Treatment of Gastric Dysplasia
Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy